Viridian Therapeutics to Webcast Veligrotug Section 3 THRIVE-2 Topline Outcomes on December 16, 2024 By Investing.com
- The THRIVE-2 world part 3 medical trial evaluated the efficacy and…
NeuroSense Aligns With FDA On Section 3 Examine Of ALS Drug By Investing.com
CAMBRIDGE, Mass. – NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a micro-cap biotechnology firm…
Beam Therapeutics Announces New Data from the BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting
All seven patients treated with BEAM-101 achieved hemoglobin F (HbF) induction >…
Incyte Announces Positive Results from Phase 3 Trial Evaluating Retifanlimab (Zynyz ®) in Combination with Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer
” Phase 3 POD1UM-304 trial met primary endpoint of overall survival (OS)…
Cabinet Decision: Rithala-Kundli corridor in Delhi Metro Phase IV gets nod with an outlay of Rs 6,230 cr
The Union Cabinet on Friday approved the Rithala-Kundli corridor of the Delhi…
